Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...
Novo Nordisk’s oral Wegovy gets FDA approval, but rising costs and competition threaten profits. Learn why analysts rate NVO ...
The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.
The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...
The FDA approved the first oral GLP-1 for lowering body weight according to a press release from Novo Nordisk. Oral ...
Oral bacteria that migrate to the gut can generate metabolites that reach the brain and accelerate Parkinson’s disease.
Scientists are discovering that the oral microbiome—home to hundreds of species of bacteria and fungi—may help predict ...
An oral formulation of semaglutide has received United States Food and Drug Administration approval for a new drug or biologic under the Prescription Drug User Fee Act. The University of Alabama at ...
MedPage Today on MSN
Once-Weekly Oral Combo for HIV Maintains High Rates of Virologic Suppression
A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of virologic ...
Smoking marijuana can increase cavities, tooth loss and the risk of oral cancers — but you can take steps to protect yourself.
High levels of the periodontal bacterium Fusobacterium nucleatum may be associated with more severe disability in people with multiple sclerosis.
What Is Oral Lichen Planus? Oral lichen planus is a long-lasting disease that affects your mouth, causing symptoms such as painful white patches, redness, and swelling. It doesn't go away, but you may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results